NIBNA: a network-based node importance approach for identifying breast cancer drivers
暂无分享,去创建一个
[1] Ga-Hang Lee,et al. FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5/NOTCH2 signaling node , 2018, Oncogene.
[2] J. P. Hou,et al. DawnRank: discovering personalized driver genes in cancer , 2014, Genome Medicine.
[3] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .
[4] Ying Fan,et al. Identifying and Characterizing Nodes Important to Community Structure Using the Spectrum of the Graph , 2011, PloS one.
[5] J. Bonneterre,et al. Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. , 1993, European journal of cancer.
[6] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[7] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[8] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[9] H. Dweep,et al. miRWalk2.0: a comprehensive atlas of microRNA-target interactions , 2015, Nature Methods.
[10] Edward Ott,et al. Characterizing the dynamical importance of network nodes and links. , 2006, Physical review letters.
[11] J. Ingle,et al. Differential Gene Expression of TGFβ Inducible Early Gene (TIEG), Smad7, Smad2 and Bard1 in Normal and Malignant Breast Tissue , 2004, Breast Cancer Research and Treatment.
[12] David Tamborero,et al. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes , 2013, Bioinform..
[13] Mithat Gönen,et al. The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. , 2011, The Journal of clinical investigation.
[14] Steve Harenberg,et al. Community detection in large‐scale networks: a survey and empirical evaluation , 2014 .
[15] E. Ott,et al. Spectral properties of networks with community structure. , 2009, Physical review. E, Statistical, nonlinear, and soft matter physics.
[16] Sun-Mi Park,et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.
[17] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] A. Vinayagam,et al. A Directed Protein Interaction Network for Investigating Intracellular Signal Transduction , 2011, Science Signaling.
[19] Finn Drabløs,et al. Update of the FANTOM web resource: high resolution transcriptome of diverse cell types in mammals , 2016, Nucleic Acids Res..
[20] Athanasios Fevgas,et al. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions , 2014, Nucleic Acids Res..
[21] Jinguang Wang,et al. Bioinformatics analysis of gene expression profiles to identify causal genes in luminal B2 breast cancer , 2017, Oncology letters.
[22] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[23] T. Tan,et al. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients , 2014, EMBO molecular medicine.
[24] A. Gonzalez-Perez,et al. Functional impact bias reveals cancer drivers , 2012, Nucleic acids research.
[25] R. Walker,et al. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients , 2007, British Journal of Cancer.
[26] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[27] M. Asaduzzaman,et al. Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer , 2017, Breast Cancer Research and Treatment.
[28] M. J. van de Vijver,et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. , 2006, Journal of the National Cancer Institute.
[29] L. Saal,et al. Refinement of breast cancer molecular classification by miRNA expression profiles , 2019, BMC Genomics.
[30] Illés J. Farkas,et al. CFinder: locating cliques and overlapping modules in biological networks , 2006, Bioinform..
[31] Jean-Loup Guillaume,et al. Fast unfolding of communities in large networks , 2008, 0803.0476.
[32] H. Kim,et al. Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer , 2014, British Journal of Cancer.
[33] Jiuyong Li,et al. CBNA: A control theory based method for identifying coding and non-coding cancer drivers , 2019, PLoS Comput. Biol..
[34] W. Mikulits,et al. Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells. , 2007, Carcinogenesis.
[35] Kaitlin G Scheer,et al. Combinatorial Targeting by MicroRNAs Co-ordinates Post-transcriptional Control of EMT. , 2018, Cell systems.
[36] E. Mardis,et al. PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance) , 2016, npj Breast Cancer.
[37] O. Wolkenhauer,et al. E2F1 induces miR‐224/452 expression to drive EMT through TXNIP downregulation , 2014, EMBO reports.
[38] Zemin Zhang,et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis , 2019, Nucleic Acids Res..
[39] Hsien-Da Huang,et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database , 2015, Nucleic Acids Res..
[40] B Marshall,et al. Gene Ontology Consortium: The Gene Ontology (GO) database and informatics resource , 2004, Nucleic Acids Res..
[41] D. Bartel,et al. Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.
[42] Ming Lu,et al. TransmiR: a transcription factor–microRNA regulation database , 2009, Nucleic Acids Res..
[43] A. Barabasi,et al. Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets , 2015, Proceedings of the National Academy of Sciences.
[44] A. Bashashati,et al. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer , 2012, Genome Biology.
[45] Xiaowei Wang,et al. OncomiR: an online resource for exploring pan-cancer microRNA dysregulation , 2018, Bioinform..
[46] Joshua D. Campbell,et al. NetSig: network-based discovery from cancer genomes , 2017, Nature Methods.
[47] Nitesh V. Chawla,et al. Complex networks as a unified framework for descriptive analysis and predictive modeling in climate science , 2011, Stat. Anal. Data Min..
[48] Xiulan Zhao,et al. The suppression of DUSP5 expression correlates with paclitaxel resistance and poor prognosis in basal-like breast cancer , 2018, International journal of medical sciences.
[49] Dong Chen,et al. JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters. , 2011, Molecular endocrinology.
[50] H. Lane,et al. Modulation of p27/Cdk2 complex formation through 4D5-mediated inhibition of HER2 receptor signaling. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[51] Gary D Bader,et al. Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers , 2013 .
[52] Mingming Jia,et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..